Otsuka (OTCMKTS:OSUKF – Get Free Report) is projected to release its resultson Thursday, April 30th. Analysts expect Otsuka to post earnings of $0.2529 per share and revenue of $2.0211 billion for the quarter.
Otsuka Price Performance
OTCMKTS:OSUKF opened at $20.77 on Thursday. The company has a 50 day moving average price of $20.76 and a 200-day moving average price of $20.61. Otsuka has a 1-year low of $19.00 and a 1-year high of $21.57.
About Otsuka
Otsuka Holdings Co, Ltd., traded as OSUKF on the OTC Market, is a global healthcare group headquartered in Tokyo, Japan. The company operates through its principal subsidiary, Otsuka Pharmaceutical Co, Ltd., and is primarily engaged in the research, development and commercialization of pharmaceutical products and nutraceuticals. Its product portfolio spans central nervous system therapies, cardiovascular and metabolic treatments, nephrology, and oncology, alongside a range of consumer wellness goods such as nutritional beverages and dietary supplements.
The origins of the Otsuka group date back to 1921 with the founding of its predecessor firm, and in 2008 the current holding company structure was established to streamline governance and strategic direction.
Featured Stories
Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.
